Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

IMATINIB vs IMDEVIMAB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

IMATINIB vs IMDEVIMAB: Safety Overview

Metric IMATINIB IMDEVIMAB
Total FAERS Reports 43,161 432
Deaths Reported 13,761 24
Death Rate 31.9% 5.6%
Hospitalizations 7,264 202
Average Patient Age 55.7 yrs 56.2 yrs
% Female Patients 47.2% 52.7%
FDA Approval Date Apr 14, 2025 N/A
Manufacturer Dr.Reddy's Laboratories Inc N/A
Route ORAL N/A
Marketing Status Discontinued N/A